Oral dosage forms
First Claim
Patent Images
1. An oral dosage form of a pharmaceutically active ingredient comprising:
- (a) an outer capsule; and
(b) non-uniform pellets, having a non-uniform shape and/or size, comprised within the capsule,wherein the pellets comprise a compressed powder comprising a pharmaceutically active ingredient.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention relates to an oral dosage form of a pharmaceutically active ingredient comprising: (a) an outer capsule and (b) non-uniform pellets, having a non-uniform shape and/or size, contained within the capsule, wherein the pellets comprise a compressed powder comprising a pharmaceutically active ingredient. In one embodiment the active ingredient is selected from the group consisting of doxycycline, omeprazole, esomeprazole, and propafenone. Pharmaceutical formulations of the active ingredients as well as methods and tools for making the oral dosage form are also described.
-
Citations
43 Claims
-
1. An oral dosage form of a pharmaceutically active ingredient comprising:
-
(a) an outer capsule; and (b) non-uniform pellets, having a non-uniform shape and/or size, comprised within the capsule, wherein the pellets comprise a compressed powder comprising a pharmaceutically active ingredient. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. An oral dosage form of a pharmaceutically active ingredient comprising:
-
(a) about 78.5 to about 79.5% by weight propafenone; (b) about 4.5 to about 5.5% by weight povidone; (c) about 4.5 to about 5.5% by weight ethyl cellulose; (d) about 9.5 to about 10.5% by weight lactose anhydrous, and (e) about 0.5 to about 1.5% by weight magnesium stearate.
-
-
19. An oral dosage form of a pharmaceutically active ingredient comprising:
-
(a) about 78.5 to about 79.5% by weight propafenone; (b) about 4.5 to about 5.5% by weight povidone; (c) about 2.5 to about 3.5% by weight glyceryl behenate; (d) about 11.5 to about 12.5% by weight lactose anhydrous; and (e) about 0.5 to about 1.5% by weight magnesium stearate.
-
-
20. A method of producing an oral dosage form of a pharmaceutically active ingredient comprising:
-
(a) compressing a powder comprising a pharmaceutically active ingredient into slugs, (b) breaking the slugs into non-uniform pellets, having a non-uniform shape and/or size, and (c) encapsulating the non-uniform pellets in a capsule. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)
-
-
33. An apparatus for making compressed powder slugs that are scored for breaking into pellets, comprising:
tooling that is adapted to compress powder into a slug, wherein at least one surface of the tooling is adapted to form scoring on at least one surface of the slug, for breaking the slug into pellets. - View Dependent Claims (34, 35, 36, 37, 38, 39, 40, 41)
-
42. A punch for making compressed powder slugs that are scored for breaking into pellets, comprising:
a device adapted to form scoring on a surface of the slug, for breaking the slug into pellets. - View Dependent Claims (43)
Specification